Trial Outcomes & Findings for Behavioral Economic Analysis of Demand for Marijuana (NCT NCT03518567)

NCT ID: NCT03518567

Last Updated: 2024-02-12

Results Overview

The Marijuana Purchase Task will be used to collect data on marijuana demand. Participants indicate how much marijuana they would purchase at varying levels of price (e.g., free - $60). Indices of marijuana demand are derived from the task and used to determine the relative value of marijuana for each participant. Hits purchased on the MPT will correspond with actual number of hits purchased and smoked in the laboratory. Primary outcome is percentage of participants who purchased and smoked exactly what they said they would.

Recruitment status

COMPLETED

Study phase

PHASE2

Target enrollment

133 participants

Primary outcome timeframe

Duration of the experimental session (i.e., 60 minutes)

Results posted on

2024-02-12

Participant Flow

Participant milestones

Participant milestones
Measure
High THC Dose (6% THC)
Smoked marijuana cigarettes (High THC dose \[6% THC\])
Overall Study
STARTED
133
Overall Study
Completed Baseline
114
Overall Study
Completed Session 1
101
Overall Study
Completed Session 2
72
Overall Study
COMPLETED
72
Overall Study
NOT COMPLETED
61

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Behavioral Economic Analysis of Demand for Marijuana

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
High THC Dose (6% THC)
n=114 Participants
Smoked marijuana cigarettes (High THC dose \[6% THC\]) Smoked marijuana cigarettes: High THC dose (6% THC): Smoked marijuana cigarettes (High THC dose \[6% THC\])
Age, Continuous
26.6 years
STANDARD_DEVIATION 5.4 • n=99 Participants
Sex: Female, Male
Female
50 Participants
n=99 Participants
Sex: Female, Male
Male
64 Participants
n=99 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
20 Participants
n=99 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
94 Participants
n=99 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=99 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=99 Participants
Race (NIH/OMB)
Asian
10 Participants
n=99 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=99 Participants
Race (NIH/OMB)
Black or African American
19 Participants
n=99 Participants
Race (NIH/OMB)
White
72 Participants
n=99 Participants
Race (NIH/OMB)
More than one race
9 Participants
n=99 Participants
Race (NIH/OMB)
Unknown or Not Reported
4 Participants
n=99 Participants

PRIMARY outcome

Timeframe: Duration of the experimental session (i.e., 60 minutes)

Population: All participants who completed Session 1 (n=101), reported purchasing at least 1 hit from a cannabis joint at their randomly selected price-point on the Marijuana Purchase Task (n=90), and chose to smoke during the Session (n=86) were included in the analysis. Outcome corresponds to percentage of participants who smoked exactly what they said they would.

The Marijuana Purchase Task will be used to collect data on marijuana demand. Participants indicate how much marijuana they would purchase at varying levels of price (e.g., free - $60). Indices of marijuana demand are derived from the task and used to determine the relative value of marijuana for each participant. Hits purchased on the MPT will correspond with actual number of hits purchased and smoked in the laboratory. Primary outcome is percentage of participants who purchased and smoked exactly what they said they would.

Outcome measures

Outcome measures
Measure
High THC Dose (6% THC)
n=86 Participants
Smoked marijuana cigarettes (High THC dose \[6% THC\]) Smoked marijuana cigarettes: High THC dose (6% THC): Smoked marijuana cigarettes (High THC dose \[6% THC\])
Validity of the Marijuana Purchase Task (MPT)
63 percentage of participants

SECONDARY outcome

Timeframe: The MCQ will be administered pre- and post- marijuana smoking during the experimental session, up to 6 hours

Population: All participants who completed Session 1 (n=101), reported purchasing at least 1 hit from a cannabis joint at their randomly selected price-point on the Marijuana Purchase Task (n=90), and chose to smoke during the Session (n=86) were included in the analysis.

Subjective marijuana craving was assessed via a 10-item Marijuana Craving Questionnaire. Participants were asked to respond to items according to how they were thinking or feeling "right now," and MCQ items were rated on a 1 = "strongly disagree" to 7 = "strongly agree" scale, with higher scores indicating greater subjective marijuana craving, and summed to yield a total craving score. Total craving score was used in analyses.

Outcome measures

Outcome measures
Measure
High THC Dose (6% THC)
n=86 Participants
Smoked marijuana cigarettes (High THC dose \[6% THC\]) Smoked marijuana cigarettes: High THC dose (6% THC): Smoked marijuana cigarettes (High THC dose \[6% THC\])
Change in Marijuana Craving Questionnaire (MCQ)
-0.75 units on the MCQ
Standard Deviation 1.09

SECONDARY outcome

Timeframe: Marijuana smoking topography indices will be collected during the 1-hour ad libitum marijuana smoking topography experimental session.

Population: Participants who completed Session 2 with usable smoking topography data.

Indices of Marijuana Smoking Topography will be obtained during the experimental session. Participants will smoke marijuana through a smoking topography device. The outcome measure is number of puffs.

Outcome measures

Outcome measures
Measure
High THC Dose (6% THC)
n=67 Participants
Smoked marijuana cigarettes (High THC dose \[6% THC\]) Smoked marijuana cigarettes: High THC dose (6% THC): Smoked marijuana cigarettes (High THC dose \[6% THC\])
Marijuana Smoking Topography
29 puffs
Standard Deviation 13.7

Adverse Events

High THC Dose (6% THC)

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Elizabeth Aston, PhD

Brown University

Phone: 401-863-6668

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place